Clinical Trials List
Protocol Number1230.16
2009-07-01 - 2011-07-31
Phase I
Terminated2
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- James Chih-Hsin Yang Division of Hematology & Oncology
- YEN-SHEN LU Division of Hematology & Oncology
- Kun-Huei Yeh Division of Hematology & Oncology
- Chiun Hsu Division of Hematology & Oncology
- Ann-Lii Cheng Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ya-Ping Chen Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
- Peng-Chan Lin Division of Hematology & Oncology
- Wen-Pin Su Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
70 participants
-
Global
70 participants
